SOMERVILLE, Mass.

萨默维尔，马萨诸塞州

,

，

June 3, 2025

2025年6月3日

/PRNewswire/ -- Matterworks, Inc., the category-defining pioneer unlocking unstructured molecular data for predictive biology, today announces new Series A financing. The round was led by Lewis & Clark Partners and OMX Ventures, joined by Pillar VC, Germin8 Ventures, Intermountain Ventures, and Tarsadia, among others.

/PRNewswire/ -- Matterworks, Inc. 是定义类别的先驱，致力于解锁非结构化分子数据以用于预测生物学，今天宣布了新一轮 A 轮融资。本轮融资由 Lewis & Clark Partners 和 OMX Ventures 领投，Pillar VC、Germin8 Ventures、Intermountain Ventures 和 Tarsadia 等跟投。

The Company will use its Series A proceeds to grow its model as a service (MaaS) business and expand its machine learning and scientific operations..

公司计划利用其 A 轮融资资金发展其模型即服务 (MaaS) 业务，并扩展其机器学习和科学运营。

Jack Geremia

杰克·格雷米亚

, Matterworks CEO and Co-Founder, 'I am delighted to partner with Lewis & Clark and welcome

`, Matterworks首席执行官兼联合创始人表示：“我很高兴能与刘易斯和克拉克合作并欢迎`

Carolyn Fritz

卡罗琳·弗里茨

to the Company's Board of Directors as we accelerate machine intelligence innovations that tackle the unsustainable cost of life science R&D.'

提交给公司董事会，因为我们正在加速机器智能创新，以解决生命科学研发不可持续的成本问题。

Carolyn Fritz

卡罗琳·弗里茨

, Operating Partner at Lewis & Clark Partners, 'In collaboration with its customers, Matterworks has repeatedly demonstrated its AI platform provides a step change reduction in the cost and throughput of mass spec quantitation.  We are excited to partner with this team in accelerating commercialization of their transformational technology.'.

刘易斯与克拉克合伙人公司的运营合伙人表示：“通过与客户合作，Matterworks屡次证明其人工智能平台能够显著降低质谱定量分析的成本并提高通量。我们非常高兴能与这支团队合作，加速推动其变革性技术的商业化进程。”

Craig Asher

克雷格·阿舍

, Managing Director from OMX Ventures, 'Matterworks is leveraging AI to unlock a new data layer for biology by making mass spectrometry accessible to all biologists. It's a shift as transformative as single-cell sequencing and we are thrilled to support this exceptional team.'

OMX Ventures的董事总经理表示：“Matterworks正在利用人工智能为生物学解锁一个新的数据层，通过使所有生物学家都能使用质谱技术。这是一个像单细胞测序一样具有变革性的转变，我们非常高兴能够支持这个卓越的团队。”

About Matterworks

关于Matterworks

Matterworks' Large Spectral Models (LSMs) productize self-supervised machine intelligence for direct machine interpretation of molecular-omic data. Pyxis

Matterworks的大型光谱模型（LSMs）将自我监督的机器智能转化为产品，用于分子组学数据的直接机器解析。Pyxis

TM

商标

, released in 2024, is the first generative AI for complete untargeted molecular annotation, unlocking new data modalities for understanding and predicting complex biological outcomes.

，于2024年发布，是首个用于完全非靶向分子注释的生成式AI，解锁了理解与预测复杂生物结果的新数据模式。

About Lewis & Clark Partners

关于刘易斯和克拉克合伙人

Lewis & Clark Partners is a

刘易斯和克拉克合伙人公司是一家

St. Louis

圣路易斯

-based group of experienced investment professionals passionate about investing in companies at the forefront of science, health, food, and agriculture innovation. We invest in growth-stage companies poised to scale nationally or globally. As founders, operators, investors, and scientists, our seasoned investment team brings deep sector expertise and insight to every investment..

我们是一群经验丰富的投资专业人士，热衷于投资于科学、健康、食品和农业创新前沿的公司。我们投资于那些准备在全国或全球扩展的成长阶段公司。作为创始人、经营者、投资者和科学家，我们资深的投资团队为每一项投资带来深厚的行业专业知识和洞察力。

About OMX Ventures

关于OMX风险投资公司

OMX Ventures is a venture capital firm focused on investing in a new era of bioengineering and its application for better tools, medicines, foods, industrial products, and more. We specialize in early stage investments at the intersection of biology, big data, and Al, with a focus on therapeutics, bio tools, diagnostics, and synthetic biology platforms..

OMX Ventures是一家专注于投资生物工程新时代及其在更好工具、医药、食品、工业产品等应用的风险投资公司。我们专注于生物学、大数据和人工智能交叉领域的早期投资，重点是治疗学、生物工具、诊断学和合成生物学平台。

SOURCE Matterworks

源物质工场

WANT YOUR COMPANY'S NEWS

想要贵公司的新闻吗？

FEATURED ON PRNEWSWIRE.COM?

荣登PRNEWSWIRE.COM？

440k+

44万+

Newsrooms &

新闻编辑室 &

Influencers

影响者

9k+

9k+

Digital Media

数字媒体

Outlets

插座

270k+

27万+

Journalists

记者

Opted In

已选择加入

GET STARTED

开始使用